Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0I3XA
|
||||
| Former ID |
DNC002338
|
||||
| Drug Name |
Ciproxifan
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Dementia; Obesity [ICD9: 290-294, 278; ICD10:F01-F07, E66] | Investigative | [538780] | ||
| Formula |
C16H18N2O2
|
||||
| InChI |
InChI=1S/C16H18N2O2/c19-16(12-3-4-12)13-5-7-15(8-6-13)20-9-1-2-14-10-17-11-18-14/h5-8,10-12H,1-4,9H2,(H,17,18)
|
||||
| InChIKey |
ACQBHJXEAYTHCY-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 184025-19-2
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
14774960, 29217532, 29217533, 43016263, 47434879, 47583760, 50070539, 50071174, 52113953, 53790071, 57298923, 57304380, 57366836, 85209025, 90341100, 103177393, 114520252, 123051072, 127387036, 131549292, 135323023, 135650102, 137007869, 137156933, 144235387, 152258581, 160647417, 162205198, 163641900, 177749578, 186014464, 189024876, 198972741, 198993150, 225089285, 229360424, 242060244, 249979315, 251883549
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-2A adrenergic receptor | Target Info | Antagonist | [536039] | |
| 5-Hydroxytryptamine 3 receptor | Target Info | Antagonist | [536039] | ||
| Histamine H3 receptor | Target Info | Antagonist | [536039] | ||
| Alpha-2C adrenergic receptor | Target Info | Antagonist | [536039] | ||
| Reactome | Adrenoceptors | ||||
| Adrenaline signalling through Alpha-2 adrenergic receptor | |||||
| Adrenaline,noradrenaline inhibits insulin secretion | |||||
| G alpha (i) signalling events | |||||
| G alpha (z) signalling events | |||||
| Surfactant metabolismR-HSA-390650:Histamine receptors | |||||
| G alpha (i) signalling eventsR-HSA-390696:Adrenoceptors | |||||
| Surfactant metabolism | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.